1^st Interim Report January – March 2009

1. Letter to the Shareholders
2. Group Management Report
3. Consolidated Financial Statements
4. Notes
5. Downloads
6. Imprint

Outlook

The Company’s most recent guidance was given in February 2009. The Company estimates full-year 2009 Group revenues between € 80 million and € 85 million, and an operating profit of € 8 million to € 11 million, including investments in technology and product development in the amount of € 18 million to € 20 million (2008: € 7.7 million). At the occasion of the reporting of the financial results of the first three months of 2009, MorphoSys reconfirmed full year guidance.

1. Industry Overview
2. MorphoSys Share Price Performance
3. Financial Analysis
4. Human Resources
5. Business Development
6. Quality Management
7. Research & Development / Alliance Management
8. Intellectual Property
9. Risk and Opportunity Report
10. Outlook

Next   Previous